Search Results - Lauren DiPetrillo
- Showing 1 - 4 results of 4
-
1
A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers by Bernard L. Silverman, William Martin, Aslı Memişoğlu, Lauren DiPetrillo, Christoph U. Correll, John M. Kane
Published 2017Artigo -
2
-
3
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia by William Martin, Christoph U. Correll, Peter J. Weiden, Ying Jiang, Sanjeev Pathak, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich
Published 2019Artigo -
4
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial by Maurizio Fava, Aslı Memişoğlu, Michael E. Thase, J. Alexander Bodkin, Madhukar H. Trivedi, Marc de Somer, Yangchun Du, Richard Leigh-Pemberton, Lauren DiPetrillo, Bernard L. Silverman, Elliot Ehrich
Published 2016Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Alternative medicine
Olanzapine
Pathology
Placebo
Psychiatry
Psychology
Randomized controlled trial
Schizophrenia (object-oriented programming)
Adverse effect
Anesthesia
Body weight
Opioid
Receptor
Tolerability
Weight gain
(+)-Naloxone
Adjunctive treatment
Amygdala
Antagonist
Antidepressant
Antipsychotic
Atypical antipsychotic
Buprenorphine
Clinical endpoint
Discontinuation
Dopamine antagonist
Double blind
Exacerbation